Anti-depressant like effect of pimozide in acute and chronic animal models of depression

Indian Journal of Pharmaceutical Education and Research

Volumn 45, Issue 1, 2011, Pages 46-53

  Mahesh, Radhakrishnan ^a   Pandey, Dilip Kumar ^a   Bhatt, Shvetank ^a   Gautam, Baldev Kumar ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

5 HT7 antagonist; Anti depressant like effect; Forced swim test; Olfactory bulbectomy; Pimozide

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; PAROXETINE; PIMOZIDE; RESERPINE; SEROTONIN; SEROTONIN 7 RECEPTOR;

ACUTE DISEASE; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DISEASE; CHRONIC DRUG ADMINISTRATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; EMOTIONALITY; FORCED SWIMMING TEST; HYPOTHERMIA; MALE; MONOTHERAPY; MOUSE; NONHUMAN; OLFACTORY BULBECTOMY; OPEN FIELD BEHAVIOR; RAT; SCORING SYSTEM; SEROTONINERGIC SYSTEM; SINGLE DRUG DOSE;

EID: 79952390175     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Lopez-Rodriguez M L, Benhamu B, Morcillo M J, Porras E, Lavandera J L, Pardo L. Curr. Med. Chem. 2004; 4: 203-210.
2. Ruat M. Molecular cloning, characterization, and localization of a high-affinity serotonin receptor (5-HT7) activating cAMP formation. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 8547-8551.
3. Gustafson EL, Durkin MM, Bard JA, Zgombick J, Branchek TA. A receptor autoradiographic and in situ hybridization analysis of the distribution of the 5-HT7 receptor in rat brain. Br. J. Pharmacol. 1996; 117: 657-666.
4. Hedlund PB, Sutcliffe JG. Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol. Sci. 2004; 25: 481-486.
5. Thomas DR, Atkinson PJ, Hastie PG, Roberts JC, Middlemiss DN, Price GW. [3H]-SB-269970 radiolabels 5-HT7 receptors in rodent, pig and primate brain tissues. Neuropharmacology. 2002; 42: 74-81.
6. Thomas D R, Hagan JJ. 5-HT7 Receptors. Curr. Drug Targets CNS Neurol. Disord.2004; 3: 81-90.
7. Varnas K, Thomas DR, Tupala E, Tiihonen J, Hall H. Distribution of 5-HT7 receptors in the human brain: a preliminary autoradiographic study using [3H]SB-269970. Neurosci. Lett. 2004;367:313-316.
8. Sleight AJ, Carolo C, Petit N, Zwingelstein C, Bourson A. Identification of 5-hydroxytryptamine7 receptor binding sites in rat hypothalamus: sensitivity to chronic antidepressant treatment. Mol. Pharmacol.1995; 47: 99-103.
9. Yau JL, Noble J, Seckl JR. Acute restraint stress increases 5-HT7 receptor mRNA expression in the rat hippocampus. Neurosci. Lett. 2001; 309: 141-144.
10. Guscott M, Bristow LJ, Hadingham K, Rosahl TW, Beer M.S, Stanton JA, Bromidge F, et al. Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression. Neuro-pharmacology. 2005; 48: 492-502.
11. Nandam LS, Jhaveri D, Bartlett P. 5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating de-pression. Clin. Exp. Pharmacol. Physiol. 2007; 34: 546-551.
12. Plassat JL. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol.1993; 44: 229-236.
13. Roth BL. Binding of typical and atypical antipsychotic agent s to 5-hydroxyt rypt amine -6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther. 1994; 268: 1403-1410.
14. Mullins UL. Effects of antidepressants on 5-HT receptor 7 regulation in the rat hypothalamus. Neuropsycho pharmacology. 2001; 21: 352-367.
15. Rebecca L S, Nicholas M B. Selective labelling of 5-HT7 receptor recognition sites in rat brain using [ 3 H]5-carboxamidotryptamine. Neuropharmacology. 1998;37: 1611-1619.
16. Burgman J. A multicentric evaluation pimozide. Acta neurologica Psychiat. 1968; 68: 875-880.
17. Boss,A.B. A follow up item analysis of the taylor Anxiety scale-J Clin. Psycho. 1955; 11: 19-55.
18. Porsolt RD, Bertin A, Jalfre M. Behavioural despair in mice: a primary screening test for anti-depressants. Arch. Int. Pharmacodyn. Ther. 1977;229: 327-336.
19. Bourin M, Fiocco AJ, Clenet F. How valuable are animal models in defining anti-depressant activity? Hum Psychopharmacol Clin. 2001; 16: 9-21.
20. Steru L, Chermat R, Thierry B and Simon P. The tail suspension test: a new method for screening antidepressant drugs. Psychopharmacol. 1985; 85: 367-370.
21. Song C, Leonard BE. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev. 2005; 29: 627-647.
22. Ramamoorthy R, Radhkrishnan M, Borah M. Antidepressant-like effects ofserotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models. Behav. Pharmacol. 2008; 19: 29-40.
23. Bourin M, Fiocco AJ, Clenet F. How valuable are animal models in defining anti-depres sant activity? Human Psychopharmacol Clin. 2001; 16: 9-21.
24. Boissier JR, Simon P. Action of caffeine on the spontaneous motility of the mouse. Arch. Int. Pharmacodyn. Ther. 1965; 158: 212-221.
25. Kelly JP, Wyrnn AS, Leonard BE. Olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther. 1997; 74: 299-316.
26. Pandey DK, Rajkumar R, Mahesh R, Radha R. Depressant-like effects of parthenolide in a rodent behavioural antidepressant test battery. J. Pharm. Pharmacol. 2008; 60: 1643-1650.
27. Brady JV, Nauta W J. Subcortical mechanisms in emotional behaviour: the duration of affective changes following septal and habenular lesions in the albino rat. J Comp Physiol Psychol. 1955; 48: 412-420.
28. Shibata S, Nakanishi H, Watanabe S, Ueki S. Effects of chronic administration of anti-depressants on mousekilling behavior (muricide) in olfactory bulbectomized rats. Pharmacol Biochem Behav. 1984; 21:225-230.
29. Mahesh R, Rajkumar R, Minasri B, Venkatesha Perumal R. Potential antidepressants: pharmacology of 2-(4-methylpiperazin-1-yl)-1,8-naphthyridine-3-carbonitrile in rodent behavioral models. Pharmazie 2007, 60, 919-924.
30. Randrup A, Munkvad I, Fog R, Gerlach J, Molander LM, Kjellberg B, Scheel-Kruger J. Mania, depression and brain dopamine. In: Essman, W B, Valzelli L. (Eds.), Current developments in psychopharmacology. Spectrum Publications, New York, 1975; 206-248.
31. Borsini F, Meli A. Is the forced swimming test a suitable model for revealing anti-depressant activity? Psychopharmacology.1988; 94: 147-160.
32. Englert LF, Ho BT, Taylor D. The effects of (-)-deltatetrahydrocannabinol on reserpine-induced hypothermia in rats. Br J Pharmacol. 1973; 49: 243-252.
33. Lumia AR, Teicher MH, Salchli F, Ayers E, Possidente B. Olfactory bulbectomy as a model for agitated hyposerotonergic depression. Brain Res. 1992; 587: 181-185.
34. Slotkin TA, Miller DB, Fumagali F, Mccook EC, Zhang J, Bissette G, Seidler FJ. Modeling geriatric depression in animals: biochemical and behavioural effects of olfactory bulbectomy in young versus aged rats. J Pharmacol Exp Ther. 1999; 289: 334-345.
35. Van Reizen H, Leonard BE. Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory Bulbectomised rats. Pharmacol Ther. 1990; 47: 21-34.
36. Lore R, Flannelly K, Farina P. Ultrasounds produced by rats accompany decrease in intra specific fighting, Aggress Behav. 1976; 2: 175-181.
37. Vivian J A, Miczek K A. Opioid suppression of distress ultrasounds after social defeat in rats. Neurosci Abst. 1990; 16: 443-447.
38. Fukuchi T, Kanemoto K. Differential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control study. Int Clin Psychopharmacol. 2000; 17: 53-58.
39. Leonard M, Tuite M. Anatomical, physiological, and behavioral aspects of olfactory bulbectomy in the rat. Int Rev Neurobiol. 1981; 22: 251-286.
40. Shibata S, Watanabe S. Facilitatory effect of olfactory bulbectomy on 2-deoxyglucose uptake in rat amygdala slices. Brain Res. 1994; 665: 147-150.
41. Schafer WR. How do anti-depressant work? Prospect for genetic analysis of drug mechanism. Cell. 1999; 98: 551-554.
42. Kvachnina E, Liu G, Dityatev A. 5-HT7 receptor is coupled to Galpha subunits of heterotrimeric G12-protein to regulate gene transcription and neuronal morphology. J. Neurosci. 2005; 25: 7821-7830.